NIH joins public-private partnership to fund research on autism biomarkers

(NIH/National Institute of Mental Health) Government, nonprofit, and other private partners will fund a multi-year project to develop and improve clinical research tools for studying autism spectrum disorder. Led by James McPartland, Ph.D., of Yale University, this Biomarkers Consortium project will receive a total of $28 million over the next four years to test and refine clinical measures of social impairment in ASD in order to better evaluate potential behavioral and drug therapies.